Literature DB >> 9226481

Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution.

G De Pergola1, V De Mitrio, F Giorgino, M Sciaraffia, A Minenna, L Di Bari, N Pannacciulli, R Giorgino.   

Abstract

OBJECTIVES: To examine the relationship of obesity, body fat distribution, and fasting plasma insulin concentrations with the plasma levels of both pro-thrombotic and anti-thrombotic factors in premenopausal women.
SUBJECTS: 32 obese women with BMI > 28 and 33 age-matched non-obese = women with BMI < 25. MEASUREMENTS: (i) plasma concentrations of plasminogen activator inhibitor-1 antigen (PAI-1 Ag), plasminogen activator inhibitor-1 activity (PAI-1 activity), fibrinogen, von Willebrand factor antigen (vWF Ag), von Willebrand factor activity (vWF activity), and factor VII activity as pro-thrombotic factors; (ii) plasma concentrations of tissue plasminogen activator antigen (t-PA Ag), protein C, and antithrombin III as anti-thrombotic factors; (iii) fasting plasma insulin and glucose concentrations, and the lipid pattern (triglycerides, total and HDL-cholesterol) as metabolic parameters. The body fat distribution was evaluated by measuring the waist circumference and the waist-to-hip ratio (WHR).
RESULTS: Obese subjects had higher plasma concentrations of all pro-thrombotic factors as compared to non-obese controls (PAI-1 Ag, P < 0.001; PAI-1 activity, P < 0.05; fibrinogen, P < 0.001; vWF Ag, P < 0.001; vWF activity, P < 0.05; factor VII, P < 0.05). The plasma concentrations of PAI-1 Ag and vWF Ag were directly correlated with the waist circumference independently of other metabolic and non-metabolic variables (P < 0.05). Obese women were also characterized by higher plasma concentrations of anti-thrombotic factors such as t-PA Ag and protein C as compared to non-obese controls (P < 0.001 and P < 0.001, respectively), although these factors were not independently correlated with the waist circumference or the WHR.
CONCLUSION: Plasma concentrations of the pro-thrombotic factors are increased in obese women as compared to non-obese controls, and plasma levels of PAI-1 Ag and vWF Ag correlate with central fat accumulation specifically. Plasma concentrations of anti-thrombotic factors (namely protein C and t-PA Ag) are also raised in obese women, but they are not correlated with parameters of body fat distribution. The increase in protein C levels may represent a protective response partly counteracting the increase in pro-thrombotic factors in these individuals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226481     DOI: 10.1038/sj.ijo.0800435

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  15 in total

1.  Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial.

Authors:  Catherine Duggan; Liren Xiao; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-05       Impact factor: 4.254

2.  Dietary Weight Loss and Exercise Effects on Serum Biomarkers of Angiogenesis in Overweight Postmenopausal Women: A Randomized Controlled Trial.

Authors:  Catherine Duggan; Jean de Dieu Tapsoba; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Res       Date:  2016-07-15       Impact factor: 12.701

3.  Interactive effects of physical fitness and body mass index on risk of stroke: A national cohort study.

Authors:  Casey Crump; Jan Sundquist; Marilyn A Winkleby; Kristina Sundquist
Journal:  Int J Stroke       Date:  2016-03-25       Impact factor: 5.266

4.  Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding.

Authors:  Massimo Cugno; Roberto Castelli; Daniela Mari; Enrico Mozzi; Marco Antonio Zappa; Massimo Boscolo-Anzoletti; Giancarlo Roviaro; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2011-01-20       Impact factor: 3.397

5.  Predictive value of ovarian stroma measurement for cardiovascular risk in polycyctic ovary syndrome: a case control study.

Authors:  Giuseppe Loverro; Giovanni De Pergola; Edoardo Di Naro; Massimo Tartagni; Cristina Lavopa; Anna Maria Caringella
Journal:  J Ovarian Res       Date:  2010-11-09       Impact factor: 4.234

Review 6.  Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Kamran Qureshi; Gary A Abrams
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

Review 7.  Diabetes and Cardiovascular Disease: an Update.

Authors:  Rajaa Almourani; Bhavana Chinnakotla; Richa Patel; L Romayne Kurukulasuriya; James Sowers
Journal:  Curr Diab Rep       Date:  2019-12-11       Impact factor: 4.810

Review 8.  Coagulation and fibrinolysis abnormalities in obesity.

Authors:  G De Pergola; N Pannacciulli
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

9.  Effects of a Low Carb Diet and Whey Proteins on Anthropometric, Hematochemical, and Cardiovascular Parameters in Subjects with Obesity.

Authors:  Giovanni De Pergola; Roberta Zupo; Luisa Lampignano; Silvia Paradiso; Isanna Murro; Annagrazia Cecere; Nicola Bartolomeo; Marco M Ciccone; Gianluigi Giannelli; Vincenzo Triggiani
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2020       Impact factor: 2.895

Review 10.  Metabolic complications of obesity.

Authors:  S M Grundy
Journal:  Endocrine       Date:  2000-10       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.